PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) (“Fate”) on behalf of the company’s long-term shareholders. https://kaskelalaw.com/case/fate-therapeutics/ Recently an amended securities fraud complaint was filed against Fate on behalf of investors who purchased shares of the company’s stock between August 5, 2020 and […]

PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Dentsply Sirona Inc. (NASDAQ: XRAY) (“Dentsply”) on behalf of the company’s long-term shareholders. https://kaskelalaw.com/case/dentsply-sirona/ Recently an amended securities fraud complaint was filed against Dentsply on behalf of investors who purchased shares of the company’s stock between June 9, 2021 and

BERKELEY HEIGHTS, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a new commercial supply contract with a top-tier mid-sized dialysis operator for the supply of DefenCath(R) (taurolidine and heparin) to dialysis clinics

PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Inari Medical, Inc. (NASDAQ: NARI) on behalf of the company’s long-term shareholders. https://kaskelalaw.com/cases/inari-medical/ Recently a securities fraud complaint was filed against Inari Medical on behalf of investors who purchased shares of the company’s stock between February 24, 2022 and February

PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Globe Life Inc. (NYSE: GL), formerly known as Torchmark Corp., on behalf of the company’s long-term shareholders. https://kaskelalaw.com/case/globe-life/ Recently a securities fraud complaint was filed against Globe Life on behalf of investors who purchased shares of the company’s stock between

PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Doximity, Inc. (NYSE: DOCS) on behalf of the company’s long-term shareholders. Recently a securities fraud complaint was filed against Doximity on behalf of investors who purchased shares of the company’s stock between February 9, 2022, and April 1, 2024. According

Salt Lake City, Utah, Sept. 19, 2024 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) a leading innovator in ceramic manufacturing, today announced the successful completion of its previously announced “at-the-market” equity public offering (the “ATM Program”) which provided for the offer and sale, from time to time, of shares of

Preliminary finding of stable disease in two out of three patients at 6 months in the first subject cohort Combination of Ampligen and Imfinzi continues to be generally well-tolerated with no severe adverse events or dose-limiting toxicities OCALA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced positive

TAMPA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — IT Nation, a global community of peers, thought leaders, and experts dedicated to elevating the IT ecosystem to new heights, has announced its new award program, the IT Nation Torch Awards, which will debut at this year’s IT Nation Connect event taking place from November 6-8, 2024,

– New U.S. patent covers the design and composition of the BVP – – Positive results from ongoing preclinical studies support the potential of the BVP to deliver insulin-producing islets as a potential treatment for type 1 diabetes – DURHAM, N.C., Sept. 19, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform